Page last updated: 2024-09-05

zm 241385 and regadenoson

zm 241385 has been researched along with regadenoson in 4 studies

Compound Research Comparison

Studies (zm 241385)	Trials (zm 241385)	Recent Studies (post-2010) (zm 241385)	Studies (regadenoson)	Trials (regadenoson)	Recent Studies (post-2010) (regadenoson)
401	3	124	321	53	264

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, ZG; Jacobson, KA	1
de Lera Ruiz, M; Lim, YH; Zheng, J	1
Baker, SP; Belardinelli, L; Blackburn, B; Elzein, E; Gao, Z; Lasley, RD; Li, Z; Meyer, S; Palle, V; Zablocki, JA	1
Belardinelli, L; Biaggioni, I; Dhalla, AK; Wang, WQ; Wong, MY	1

Reviews

2 review(s) available for zm 241385 and regadenoson

Article	Year
Adenosine receptors as therapeutic targets. Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3 Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship	2006
Adenosine A2A receptor as a drug discovery target. Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction	2014

Other Studies

2 other study(ies) available for zm 241385 and regadenoson

Article	Year
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1 Topics: Adenosine; Animals; Antihypertensive Agents; Coronary Vessels; Corpus Striatum; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Male; PC12 Cells; Phenethylamines; Purinergic P1 Receptor Agonists; Purines; Pyrazoles; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Swine; Triazines; Triazoles; Vasodilation; Vasodilator Agents	2001
Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2 Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Male; Norepinephrine; Purines; Pyrazoles; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Tachycardia; Time Factors; Triazines; Triazoles	2006

Article

Year

Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.

The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:1

Topics: Adenosine; Animals; Antihypertensive Agents; Coronary Vessels; Corpus Striatum; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Male; PC12 Cells; Phenethylamines; Purinergic P1 Receptor Agonists; Purines; Pyrazoles; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Swine; Triazines; Triazoles; Vasodilation; Vasodilator Agents

2001

Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats.

The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2

Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Male; Norepinephrine; Purines; Pyrazoles; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Tachycardia; Time Factors; Triazines; Triazoles

2006